BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25655076)

  • 21. Mannosidase activity of EDEM1 and EDEM2 depends on an unfolded state of their glycoprotein substrates.
    Shenkman M; Ron E; Yehuda R; Benyair R; Khalaila I; Lederkremer GZ
    Commun Biol; 2018; 1():172. PubMed ID: 30374462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EDEM3, a soluble EDEM homolog, enhances glycoprotein endoplasmic reticulum-associated degradation and mannose trimming.
    Hirao K; Natsuka Y; Tamura T; Wada I; Morito D; Natsuka S; Romero P; Sleno B; Tremblay LO; Herscovics A; Nagata K; Hosokawa N
    J Biol Chem; 2006 Apr; 281(14):9650-8. PubMed ID: 16431915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EDEM2 stably disulfide-bonded to TXNDC11 catalyzes the first mannose trimming step in mammalian glycoprotein ERAD.
    George G; Ninagawa S; Yagi H; Saito T; Ishikawa T; Sakuma T; Yamamoto T; Imami K; Ishihama Y; Kato K; Okada T; Mori K
    Elife; 2020 Feb; 9():. PubMed ID: 32065582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EDEM1 reveals a quality control vesicular transport pathway out of the endoplasmic reticulum not involving the COPII exit sites.
    Zuber C; Cormier JH; Guhl B; Santimaria R; Hebert DN; Roth J
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4407-12. PubMed ID: 17360537
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mannosidase IA is in Quality Control Vesicles and Participates in Glycoprotein Targeting to ERAD.
    Ogen-Shtern N; Avezov E; Shenkman M; Benyair R; Lederkremer GZ
    J Mol Biol; 2016 Aug; 428(16):3194-3205. PubMed ID: 27108681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EDEM1 regulates ER-associated degradation by accelerating de-mannosylation of folding-defective polypeptides and by inhibiting their covalent aggregation.
    Olivari S; Cali T; Salo KE; Paganetti P; Ruddock LW; Molinari M
    Biochem Biophys Res Commun; 2006 Nov; 349(4):1278-84. PubMed ID: 16987498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EDEM accelerates ERAD by preventing aberrant dimer formation of misfolded alpha1-antitrypsin.
    Hosokawa N; Wada I; Natsuka Y; Nagata K
    Genes Cells; 2006 May; 11(5):465-76. PubMed ID: 16629899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EDEM2 initiates mammalian glycoprotein ERAD by catalyzing the first mannose trimming step.
    Ninagawa S; Okada T; Sumitomo Y; Kamiya Y; Kato K; Horimoto S; Ishikawa T; Takeda S; Sakuma T; Yamamoto T; Mori K
    J Cell Biol; 2014 Aug; 206(3):347-56. PubMed ID: 25092655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EDEM1 Drives Misfolded Protein Degradation via ERAD and Exploits ER-Phagy as Back-Up Mechanism When ERAD Is Impaired.
    Chiritoiu M; Chiritoiu GN; Munteanu CVA; Pastrama F; Ivessa NE; Petrescu SM
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycosylation-independent ERAD pathway serves as a backup system under ER stress.
    Ushioda R; Hoseki J; Nagata K
    Mol Biol Cell; 2013 Oct; 24(20):3155-63. PubMed ID: 23966469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trimming of glucosylated N-glycans by human ER α1,2-mannosidase I.
    Aikawa J; Takeda Y; Matsuo I; Ito Y
    J Biochem; 2014 Jun; 155(6):375-84. PubMed ID: 24519966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purified EDEM3 or EDEM1 alone produces determinant oligosaccharide structures from M8B in mammalian glycoprotein ERAD.
    George G; Ninagawa S; Yagi H; Furukawa JI; Hashii N; Ishii-Watabe A; Deng Y; Matsushita K; Ishikawa T; Mamahit YP; Maki Y; Kajihara Y; Kato K; Okada T; Mori K
    Elife; 2021 Oct; 10():. PubMed ID: 34698634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Segregation and rapid turnover of EDEM1 by an autophagy-like mechanism modulates standard ERAD and folding activities.
    Calì T; Galli C; Olivari S; Molinari M
    Biochem Biophys Res Commun; 2008 Jul; 371(3):405-10. PubMed ID: 18452703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exploration of the topological requirements of ERAD identifies Yos9p as a lectin sensor of misfolded glycoproteins in the ER lumen.
    Bhamidipati A; Denic V; Quan EM; Weissman JS
    Mol Cell; 2005 Sep; 19(6):741-51. PubMed ID: 16168370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural basis of an ERAD pathway mediated by the ER-resident protein disulfide reductase ERdj5.
    Hagiwara M; Maegawa K; Suzuki M; Ushioda R; Araki K; Matsumoto Y; Hoseki J; Nagata K; Inaba K
    Mol Cell; 2011 Feb; 41(4):432-44. PubMed ID: 21329881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of early EDEM1 protein maturation events and their functional implications.
    Tamura T; Cormier JH; Hebert DN
    J Biol Chem; 2011 Jul; 286(28):24906-15. PubMed ID: 21632540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle.
    Molinari M; Calanca V; Galli C; Lucca P; Paganetti P
    Science; 2003 Feb; 299(5611):1397-400. PubMed ID: 12610306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of ERAD of misfolded null Hong Kong alpha1-antitrypsin by Golgi alpha1,2-mannosidases.
    Hosokawa N; You Z; Tremblay LO; Nagata K; Herscovics A
    Biochem Biophys Res Commun; 2007 Oct; 362(3):626-32. PubMed ID: 17727818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quality control of glycoprotein folding and ERAD: the role of N-glycan handling, EDEM1 and OS-9.
    Roth J; Zuber C
    Histochem Cell Biol; 2017 Feb; 147(2):269-284. PubMed ID: 27803995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A luminal surveillance complex that selects misfolded glycoproteins for ER-associated degradation.
    Denic V; Quan EM; Weissman JS
    Cell; 2006 Jul; 126(2):349-59. PubMed ID: 16873065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.